Financials in USD. Standardized financial statements.
A compact view of how Filament Health Corp. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Revenue? | $616,678 | $2.13M | $364,500 | $0 | $0 |
| Revenue Growth? | -71.1% | +484.6% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $913,647 | $0 |
| Gross Profit? | $616,678 | $2.13M | $364,500 | -$913,647 | $0 |
| Gross Margin? | +100.0% | +100.0% | +100.0% | 0.0% | 0.0% |
| Operating Expenses? | $4.29M | $7.05M | $5.88M | $6.36M | $191,095 |
| Operating Income? | -$3.67M | -$4.92M | -$5.50M | -$7.10M | -$191,095 |
| EBITDA? | -$4.52M | -$4.74M | -$5.16M | -$7.08M | $0 |
| Income Before Tax | -$4.97M | -$5.32M | -$16.54M | -$9.29M | -$191,095 |
| Income Tax Expense | $0 | $0 | -$70,538 | -$37,748 | $0 |
| Net Income? | -$4.97M | -$5.32M | -$16.47M | -$9.25M | -$191,095 |
| EPS? | $-0.02 | $-0.03 | $-0.10 | $-0.06 | $-0.00 |
| Diluted EPS? | $-0.02 | $-0.03 | $-0.10 | $-0.06 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality